Eloxx Pharmaceuticals, Inc. cotiza a 12.70 USD y tiene una capitalización bursátil de $51M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia. The company is developing exaluren, a eukaryotic ribos…
| Periodo | 2023-11 | 2023-08 | 2023-05 | 2023-03 |
|---|---|---|---|---|
| Real | $-14.41 | $-21.56 | $-31.68 | $-33.55 |
| Estimado | $-21.67 | $-16.94 | $-28.05 | $-32.67 |
| Sorpresa | +33.5% | -27.3% | -12.9% | -2.7% |
| Métrica | ELOX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -113.8% | -32.0% | -81.8% |
| Current Ratio | 0.31 | 2.84 | -2.53 |
| Debt / Equity | -0.08 | 0.28 | -0.36 |